Insider trades
Daniel G. Welch, Director of Structure Therapeutics GPCR, has filed 0 purchases and 41 sales on the open market. The latest trade was on 06/17.
Daniel G. Welch
Director
- Company
- Structure Therapeutics GPCR
- First filing
- 23/02/09
- Trades
- 105 trades
- Buys / sales
- 0 / 41
- 12-month net buying
- No record
- Last trade
- 06/17
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
| Open-market sale | 23/08/28 | 23/08/29 | 4,925 sh3 trades | $209.08avg. | $1,029,712.4 | No record | |
| Open-market sale10b5-1 plan | 23/05/15 | 23/05/16 | 1,864 sh | $200.02 | $372,837.28 | −23.0% | |
| Open-market sale10b5-1 plan | 23/05/01–23/05/02 | 23/05/03 | 27,032 sh9 trades | $200.07avg. | $5,408,188.07 | No record | |
| Open-market sale | 23/04/03 | 23/04/05 | 31,000 sh12 trades | $201.61avg. | $6,249,843.9 | No record | |
| Open-market sale | 23/03/15 | 23/03/17 | 3,603 sh3 trades | $200.05avg. | $720,780.15 | No record | |
| Open-market sale | 23/03/13–23/03/14 | 23/03/16 | 27,397 sh13 trades | $200.35avg. | $5,488,901.44 | No record |